Skip to content
lifestyle.thedishh.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Sionna Therapeutics, Inc.
Sionna Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
May 13, 2026
Sionna Therapeutics Reports First Quarter 2026 Financial Results
May 12, 2026
Sionna Therapeutics Completes Enrollment in PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, Added to Standard of Care in Participants with Cystic Fibrosis
May 4, 2026
Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium
May 2, 2026
Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
March 2, 2026
Sionna Therapeutics to Participate in Upcoming March 2026 Investor Conferences
February 23, 2026
Sionna Therapeutics to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit 2026
February 7, 2026